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The current efforts underway to sequence the genome of Agrobacterium 
tumefaciens have led to the discovery of a large region of DNA (52kb) with a strong 
homology to several polyketide synthetase genes. This was a matter of great interest to 
the Agrobacterium project; no current literature documents the production of a polyketide 
or non:..iibosomal peptide from Agrobacterium. Furthermore, the multi-domain enzymes 
coded by these polyketide synthetase genes in other bacterial species are responsible for 
synthesizing several toxins, many which act as antibiotic agents {8, 9, 12, 16). This was 
also of great interest, since Agrobacterium is not known to produce any toxins, and also 
because several of these toxins produced in other species are useful antibiotic agents in 
humans. The hypothesis that Agrobacterium produces such a compound is not surprising; 
Agrobacterium is a well known plant pathogen and opportunistic human pathogen and 
lives in the soil where it must compete with various other microbes. This project was 
designed to confirm that Agrobacterium produces a polyketide or non-ribosomal peptide, 
and to determine, if possible, its structure and function. 
The original sequence of genomic DNA resembling polyketide synthetase genes 
was found, with the help of the sequencing efforts of Cereon Genomics, to be a small part 
of a large cluster of genes. The overall structure of this large gene cluster was found to be 
3 large operons, each encoding several genes with multiple domains with different 
activities (Fig 1), and the overall sequence was found to be homologous to several other 
polyketide synthetase genes via BLAST searches (Fig 2). 
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Figure 1: Each gene is shown as a series of connected boxes representing the regions encoding domains 
with different activities. Domain abbreviations: A, acyl carrier protein; C, amino acid condensation; D, 
dehydrogenase; E, thioesterase; K, B-ketoacyl synthase; M, methyltransferase; N, monooxygenase; P, 
amino acid activation; T, acyl transferase;?, unknown function. 
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Figure 2: A: Amino acid sequence entered into BLAST database. 
B: 
Oreanism Gene w/ similarity to our sequenc Probability of random chance 
Amycolatopsis 
Nostoc sp. 
mediterranei rifamycin polyketide synthase 3e-34 
Streptomyces natalensis 
Mycobacterium tuberculosis 
Sorangium cellulosum 
Sorangium cellulosum 
Mycobacterium leprae 
Sorangium cellulosum 
Sorangium cellulosum 
Sorangium cellulosum 
NosB polyketide synthase 3e-33 
polyketide synthase 9e-30 
probable polyketide synthase 3e-29 
EpoA polyketide synthase Be-29 
epoD polyketide synthase 3e-28 
polyketide synthase pksF 4e-28 
polyketide synthase Se-28 
EpoF polyketide synthase 7e-28 
polyketide synthase 7e-28 
Figure 2: B: Matches to sequence entered in A. 
Based on the arrangement of the different activity domains, it was predicted that 
that the three operons encoded a biosynthetic pathway for the synthesis of a molecule 
with 7 amino acids and 2-3 fatty acid residues. This is not surprising based on the models 
of other similar biosynthetic pathways, such as the pathway for the synthesis of 
erythromycin (Fig 3). The sequence and specificities of each activation domain were 
compared using a predictive model (21) to propose an overall amino acid structure for the 
polyketide/non-ribosomal peptide product (Fig 4). This structure was used in conjunction 
with various publications (1, 2, 3, 4, 6, 7, 10, 14, 20) to design a protocol for the isolation 
and purification of the product of the encoded enzymes. 
Obtaining a pure sample of enzyme product from a cell culture is no easy task; the 
extracellular fluid surrounding growing cells contains various nutrients, waste products, 
and any other secreted molecules. Typical toxins produced by other microorganisms are 
also extremely small and exhibit a wide range of solubility properties, often making 
simple extractions of organic molecules extremely difficult. Another important 
consideration in the purification of any gene product is the expression of the genes in 
question. Because Agrobacterium has never been shown to produce any polyketides or 
non-ribosomal peptides, it was our hypothesis that the genes responsible for the 
production of any such compounds are repressed under normal conditions. Therefore, in 
order to begin the investigation of our genes in the life of Agrobacterium, it was first 
necessary to determine when our discovered genes were turned on. 
Because we have the sequence of our genes, it was possible to construct a mutant 
in which we could monitor the expression of our genes. Using a small segment of the 
pksB gene on a PRL119 plasmid containing a promoterless lac Z operon, we constructed 
a mutant which would express the lac Z gene whenever the pks B gene was turned on (fig 
5). 
Before we could monitor for gene expression, we first had to hypothesize some 
conditions.where we would expect the cells to express the genes. If the enzyme products 
indeed produce a toxin, then we want to replicate conditions under which toxin 
production would be necessary. We hypothesized that the cells would make a toxin if 
they sensed competition in the environment, so we decided to grow the cells in a minimal 
culture to simulate other organisms competing for food. Cultures were grown in M9 
minimal media under antibiotic control and containing XGAL, and very low lac Z 
expression was noted between days 7-14. This pattern of gene expression agrees with our 
hypothesis; namely that the expression of a toxin would be appropriate as food supplies 
diminish. 
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Figure 3: The biosynthetic pathway of the formation of Erythromycin A, an antibiotic non-ribosomal 
peptide. Note the similarities in gene structure. 
Before proceeding with attempting to purify any products of the cells, we wanted 
to conduct an assay to monitor for any antimicrobial activity in cells that had grown in 
minimal media' for 7-14 days. In order to do this, it was necessary to construct a 
disruption mutant in the pks gene cluster. This would allow us to monitor antimicrobial 
activity due to only our genes in question. A pks B disruption mutant was constructed via 
homologous recombination (Fig 6) and was used in various assays outlined in this paper. 
Figure 4: A putative structure for the product of the polyketide synthetase genes in Agrobacterium based 
on a predictive model (21 ). The model cannot account for fatty acid residue structure, so only the amino 
acid backbone has been included. 
.I:'!IIWOlt"l" 
..... 
Stop codon in 3 frames 
Ribosome binding site 
pRLll9 plasmid 
Figure 5: Homologous recombination was used to construct a mutant with a lac Z insertion into the pksB 
gene. Cells incoiporating the insertion were selected by ampicillin resistance .. 
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Figure 6: Construction of a pks B disruption mutant for use in various functional assays. A plasmid with 
ampicillin resistance was inserted into the pks B gene via homologous recombination to disrupt the product 
of the genes. 
Wildtype cells were grown on minimal plates, and plugs from these plates were 
transferred onto lawns of other microbes to monitor for any inhibition activity. A small 
zone of inhibition was produced by a day 14 plug transferred onto a lawn of 
Staphylococcus (Fig 7), but the size of the inhibition zone was not significant enough to 
conclude that our genes had anything to do with antimicrobial activity. The plugs did not 
inhibit the growth of any other microorganisms (data not included). This data does not 
refute or support the claim that Agrobacterium produces a toxin, so efforts were then 
made to attempt to purify the organic components of the supernatants of growing cells. 
This would make it possible to directly monitor the effects of secreted molecules on other 
organisms. 
Figure 7: Zone of inhibition produced by plugs of 
wildtype cells on lawns of Staphylococcus. The 
figure at right is not to scale, in fact the zone of 
inhibition produced was smaller than indicated 
here. The transferred plugs of Agrobacterium had 
been grown for 14 days on minimal plates., 
1---+- zone of 
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The overall purification scheme designed for the products of Agrobacterium was 
based on the purification of various non-ribosomal products from various bacterium. In a 
general respect,- the majority ofthese compounds precipitate under acidic conditions 
when present in high concentrations. It was therefore our goal to grow large cultures of 
bacteria for 7-14 days (the amount of time our lac Z disruption took to express our genes) 
and then attempt to precipitate out our non-ribosomal product. Cell cultures, however, 
contain various other compounds that may precipitate under these conditions, and if all 
growing cells are not completely removed the supernatants can become contaminated 
with lysed cellular products. Therefore, in-order to determine which compounds might 
represent our gene products, we designed a comparative assay that used the pks B-
disruption in conjunction with the wild type. 1L cultures of wild type and pks B- cells were 
grown for 7 days, at which time 500ml of each culture was removed and centrifuged at 
high speed. The resulting supernatants were stored at 4°C. For the next 7 days, 1ml of 
each culture was removed, centrifuged, and refrigerated. At day 14, the remaining 
cultures were centrifuged and supernatants were stored for further experimentation. 
Now that supernatants had been obtained for days 7-14 for both strains of cells, 
the purification process could begin (note: the large portions of obtained supernatants 
were from days 7 and 14. The 1ml cultures collected between these days were obtained to 
monitor if the concentrations of any cell products increased over these days). The 
solutions were made acidic (pH 2.0) by adding concentrated HCl, and the solutions were 
stored for 48hrs at 4°C. The solutions were then centrifuged (13,000rpm) and 
supernatants were discarded. The resulting pellets were washed several times with acidic 
water, washed 3 times in hexane to remove any free fatty acids or alcohols, and then 
dissolved in alkaline water. The resulting solutions were frozen in liquid nitrogen and 
lyophilized. The collected pellets were stored at -20°C for further experimentation. 
The pellets were finally dissolved in diethyl ether (after trying various organic 
solvents) and run on silica TLC paper under various mobile phases to asses for the 
presence of any organic solvents. Results for days 7-14 TLC are included below (Fig 8). 
It seemed clear that several organic molecules were 
present in our lyophilized pellets from the wildtype 
cells. Upon high magnification, we discovered an 
area in each sample (indicated with arrows) that 
appeared to increase in concentration between days 7-
14. This was consistent with both our hypothesis and 
the results of our lac Z disruption assays (XGAL 
breakdown increased over the 7-14 day period, 
indicating ari increase in gene expression). This 
became'o~~primary area of interest. However, this 
sp'ot on the TLC plate is too close to other spots to 
purify this c~inpo~nd in the current mobile phase. 
Therefore, 'effo'rts ~ere made to discover a mobile 
• '".¥- , .• 
. Figure 8: Thin layer ~IU:omatography of dried pellets 
dissolved in diethyl ether under a 1:1 v/v diethy1 
'ether/pentane mobile phase. Each spot represents a pellet 
obtained from each day (7-14 left to right). Note the increase 
in concentration of the indicated area as the days progress. 
phase that would separate the spot in question from the other dissolved molecules. After 
several trials, pure chloroform proved the best in isolating the spot in question. Several 
attempts including pure chloroform (indicated with an arrow) are included (Fig 8). 
Now that we had developed a way to separate the 
molecule in question from the other dissolved 
c'ompounds, we wanted to assay the disruption mutant 
to see ifthe expression of this compound differed in 
atiy way. We would expect that ifthe indicated spot 
was indeed the product of our disrupted genes, our 
mutant cell supernatants should produce different 
results. This is exactly what we found. When pellet 
samples from both widtype and mutant cells were run 
in parallel, the spot found on the wildtype plate was 
completely absent in the mutant assay (Fig 9). 
Figure 9: TLC ofWT pellets in various solvents in 
attempts to separate organic compounds. Clearly, 
the second plate from the left (indicated) produced 
the best separation (chloroform mobile phase), so 
this mobile phase was selected for all further 
experimentation. Spots were resolved with short 
waveUV. 
All results obtained so far supported our 
hypothesis that a: the pellets we obtained may contain 
the product of our genes, and b: we had obtained a 
suitable purification scheme that would allow us to separate 
whatever this compound was. There was no way of proving 
that the spot was the product of our genes; but most of the 
evidence pointed in this direction. It then seemed appropriate 
to move onto a more rigorous purification scheme that would 
allow us to collect some of the purified product for analysis. 
In order to collect a crudely purified product, a 1 Ocm 
elution column containing silica gel was constructed. The 
remaining pellets (both WT and mutant for days 7 and 14) 
were dissolved in 1ml of chloroform and poured into the 
elution column. The column was eluted with diethyl ether, 
and 50 1ml samples of elutant were collected for analysis. 
1> 
•• 
Each 1ml sample was spotted on TLC plates 
and resolved with short wave UV (data not 
included). Samples l-6 in both WT and 
mutant assays (both days 7 and 14) resolved a 
spot, coordinating with the resolved spot at the 
top of the plate in figure 10. In addition, the 
Figure 10: TLC ofwildtype (right) and mutant (left) 
pellets dissolved in ether and run in chloroform mobile 
phase. Note the indicated spot on the wildtype plate that 
is absent in the disruption plate. Spots were resolved 
with short wave UV. 
WT day 7 and day 14 pellets resolved a spot in samples 14-17 (note: the spot in day 14 
pellet was much darker, indicating a higher concentration as in figure 8, with no 
corresponding spot in the mutant). These samoles were combined, resulting in a 3ml 
sample for both days 7 and 14 for the wildtype. For demonstration purposes, samples 14-
17 in the mutant were also combined, and all four resulting solutions were spotted on 
TLC plates and run in a chloroform mobile phase (Fig 11). 
Now that we had obtained samples from the WT 
that contained one spot that the disruptions did not, we 
were ready to move onto some spectroscopic analysis. 
The samples for days 7 and 14 for the wildtype strain 
were combined and the solvent was 
evaporated under reduced pressure to yield 
approximately .2mg ofbrown crystals. The 
crystals were heated in a 1 00°C oven in a 
.5 ml head space MS tube, and 1 ul of head 
space air was collected and injected into a 
Hewlett-Pakard model 5890 series MS with 
Figure 11: Spots were resolved (from left to right); 
WT day 7, WT day 14,pks B- day 7,pks B day 14, in 
a chloroform mobile phase and resolved with short 
wave UV. Note the presence of a spot that increases 
in concentration in the WT from day 7 to 14. This 
spot is absent in both mutant samples. 
a GC inlet system. No spectrum was produced due to the low volatility of the crystals. 
The remaining brown crystals were dissolved in D20 and analyzed in a GE 
300MHz NMR system locked to the deuterium resonance of the solvent D20. These 
experiments produced the following 1H and 13C spectra (Fig 12). 
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bre 12: A: 300MHz ID carbon spectrum of unknown crystals. Signals were recoreded at 15,20 and 55 ppm. B: 300MHz ID 
lrin spectrum of unknown crystals. Signals recorded were at .2, 1.5, and 2.8ppm . 
. :, The data collected in this series ofNMR experiments is inconclusive. The most 
likely cause of such weak signals is the small sample size we used, however we would 
have expected at least some signals upfield from the ones we obtained. To confirm this, 
we compared ourdata with the NMR analysis ofLichenysin A, a non-ribosomal peptide 
similar in structure to our putative structure (Fig 13). 
Figure 13: 
Structure of 
Lichenysin A, a 
non-ribosomal . 
· peptide similar 
to our proposed 
structure (20). 
Lichenysin A prod~ces strong signals at 9.8ppm, 7.4ppm, 4.38ppm, and 2.0lppm. 
We would have expected to at least see some stronger peaks up field of the deuterium 
signal produced at 4:8. In addition, investigators were able to obtain a GC-MS of 
Lichenysin A on the same machine described here. Collectively, these results suggested 
that our purification scheme did not successfully purify any non-ribosomal peptide . 
. To gain further knowledge into any function of our purified components, 
:concentrated samples ofthe'dissolved pellets were spotted onto plates of Staphylococcus 
·to'm~nitor for any growth. inhibition. There was no inhibition of growth at any 
concentration (data not included); no antimicrobial activity was observed. 
0 
Whether we had purified correctly or not, it was our contention that 
Agrobacterium was expressing the pks genes at low levels to begin with, so we deemed it 
appropriate to approach the problem in a new way. Because we knew the sequences of 
the genes and the nucleotides between the operons, we decided to attempt to clone out 
each operon and assemble them under controlable promoters in E. coli. This way we 
could attempt to constitutively express our genes and attempt to collect high 
concentrations of product. We used an Expand Long Template PCR System (Roche) and 
attempted to clone out each operon for ligations and transformations. We monitored for 
fragments ofthe appropriate size for our operons (12.8kb, 8.3kb, 21.8kb). We tried 
several times at various Tm's but failed to obtain any clones (data not included). 
Currently we are making-efforts to construct a mutant with the entire pks gene 
sequence removed. We have obtained a ClonePlex-AK Library construction kit (Lucigen) 
which is normally used to clone two DNA fragments independently into the same vector. 
The pLE:XX-AK vector used contains two dispersed Hindi cloning sites, each flanked by 
two' different antibiotic resistance genes (Fig 14). We used sequences flanking the cluster 
ofpks genes to designprimers to clone the entire region into the pLEXX-AK vector, 
leaving the genomic DNA without the pks genes and inserting the entire region into the 
plasmid. This would result in a mutant ready for all sorts of functional assays, as well as a 
potentially recoverable plasmid containing the entire region ofbiosynthetic genes. 
~tandard Cloning Vector ClonePiex~AK Vector 
' ., . ,, ,/· 
~ultiple Cloning Site 
p~C_19 
2.8-kb 
P2 
.....-
-pLEXX-AK 
2.7 kb 
Figure 14: Schematic diagram illustrating the difference between conventional cloning vectors and the 
ClonePlex'pLEXX-AK duplex cloning vector. Pl-P4 indicate primer binding sites. Amp: ampicillin 
resistance gene; Kan: kanamycin resistance gene; lacZa: alpha fragment of the p-galactosidase gene; Ori: 
origin of replication; Hindi: cloning site for blunt end DNA fragments. 
Hi nell 
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_We have already obtained the primers necessary for the reaction and have 
converted theoverhanging ends into phosphorylated blunt ends and ligated them to the 
vector . .Thevectoris rio,w ready for'electroporation into E. coli. 
·': . · .· .. · It see~~ that these new genetic approaches will be the answer to discovering the 
fu~ction'ofthe genes in question. Because the genes do not seem to be expressed under 
no~'afconditioris, we must now direct our efforts to genetic manipulation. The fact that 
the' expression' ofthese genes is repressed may suggest a role in the function ofthe genes, 
and may also' provide clues as to the evolutionary background of the putative polyketide 
syntheta~e 'genes themselves. While we are making progress on analyzing the genes via 
PCR~'further efforts should be_ made into investigating the role ofthese genes in vivo. 
There,must'be some environmental cues that enhance the expression of these genes, 
aithough t~e conditions that stimulate other bacteria to make these compounds have 
failed to do so at high levels. Nevertheless, more rigorous chemical purification (HPLC 
'or affinity chromatography) may be sufficient to obtain larger amounts of non-ribosomal 
peptide for analysis. It is also worth mentioning that F AB-MS experiments will provide 
clues as to the nature of the compound isolated from the wildtype strain; it is of interest 
,because the mutant strain failed to produce it. It should be noted that no assays other than 
'the fa~ Z disruption have been conducted to directly monitor gene expression, so future 
efforts should include a more reliable method to monitor gene expression. Until that time 
the 'role ?f the J?ks cluster in Agrobacterium tumefaciens remains unclear. 
Materials and Methods 
Microorganisms and culture conditions: 
Agrobacterium tumefaciens strain A348 was used throughout this work. Stocks of 
bacteria were stored in frozen glycerol cultures at -70°C. The cultures were grown in M9 
minimal media with sucrose as a carbon source. Bacterial growth in minimal media was 
monitored by measuring optical density at 600nm. 
Construction of mutants: 
Strain A348 cells were subjected to homologous recombination and two mutant strains 
were derived. A lacZ insertion mutation under ampicillin control was inserted into the 
pks B ~gene for the monitoring of gene expression, and a pRL 119 plasmid was inserted 
into the 'vks B gene to create a disruption mutant. 
Inhibition assays: 
A348 cells were grown on M9 minimal plates for 7-14 days at 28°C. Plugs from these 
plates\vere'transferred onto lawns of E. coli and Staphylococcus, and plates were 
incubated for24h at 37°C to monitor for growth inhibition. 
Compound isolation: 
Bacterial cells were removed from M9 minimal media after 7-14 days by centrifugation 
(13,000 x'g, 4°C, 15 min). The supernatant was subjected to acid precipitation by adding 
concentrated HCl to achieve a final pH of2.0 and allowing the precipitate to form at 4°C 
for 48h. The pellet was collected by centrifugation and washed several times with acidic 
water'"(I>Hi:O withconcentrated HCl), dissolved in alkaline water (pH 8.0 with NaOH), 
ancf'lyophilized overnight. The dried product was extracted with diethyl ether, solvent 
was removed with the aid of a rotary evaporator under reduced pressure, and the solid 
was washed with 3 volumes ofhexane to remove alkanes, free fatty acids, and alcohols. 
The crude material was collected for further purification by the chromatographic 
procedures described below. 
Thin layer and adsorption chromatography was carried out on silica gel plates and 
elution columns (B&J Inert SPE System, Burdick and Jackson, Muskegon, Mich.) with 
solvents of gradually increasing polarity: chloroform > acetone> chloroform : methanol 
(2: 1) >methanol. The chloroform elutate demonstrated the greatest separation, so the 
compounds were separated in a silica gel column using this mobile phase. The product 
was dialyzed against sterile, distilled water overnight to remove the remaining cations 
and stored at ..:2ooc. 
Other TLC systems tested included chloroform-methanol-acetone-acetic acid 
90:1 0:6:'1 and chloroform-methanol-acetone 90:10:6. 
GC-Ms:· ' 
GGpos:itive-ion electron' impact was performed withaMS 5989A system (Hewlett-
Packard)·: The ion source was maintained at 200°C. Injections were made {l)ll) with a 
Hewlett-Packard autosampler in the on-column mode. The hydrogen carrier gas flow rate 
was 21crnls. The oven temperature ranged from 100 to 280°C. the injector was 
maintained in the overtracking mode. The temperature of the detector was 325°C. 
NMR: 
All one dimentional NMR spectra were recorded on aGE 300MHz NMR spectrometer 
locked to the deuterium resonance ofthe solventD20, without spinning. 
PCR: 
In our first attempt to PCR each operon separately, the following primers were used: 
Operon,l:· 
pksABCDE (should amplify 12778 bp) 
AB-1 (38 bases) 5'-gcTcTAgATcAggAgTTTTTcAgATgcAgATcATAccg-3' 
AB-2 (30 bases) 5'-gcAgATcTATggAcAcATcAgcccgccTcg-3' 
Operon2: · 
pksFGHII'I" (should amplify 8296 bp) 
FG.:1 (43 bases) 
5'..:~cgAATT~TAgAgccAAggggcggcTTATgAATTAcATcgAgc-3' 
FG-2 (37 bases) 5'-cgAgcTcAAgcTTAAcAcgcAcgTTAcTTgTggAAcg-3' 
Operon 3: 
pksJLKMN (should amplify 21787 bp) 
JK-1 (37 bases) 5'-ggggTAccAgcgAgAAcTgcccATgTccgAcTATAcc-3' 
JK-2 (31 bases) 5'-gcTcTAgATcAggcTcATgcAgTTcTggTTg-3' 
In our second attempt to PCR the entire region, the following sequences were used for 
primers: 
OLIGO start len tm gc% any 3' seq 
LEFT PRIMER 643 25 61.73 48.00 6.00 2.00 
CTTTACGGTCTCCTCTATGATCAGC 
RIGHT PRIMER 1616 24 67.00 50.00 4.00 0.00 
CACTTGGCCTGTCTTTGATGGTTG 
OLIGO start len tm gc% any 3' seq 
LEFT PRIMER 211 24 60.98 45.83 4.00 0.00 
GTTACATTCCCAGTCCATGTCTTC 
RIGHT PRIMER 1217 25 60.61 44.00 4.00 3.00 
GTGTAGGTGAAGGGTTCTTTTAAGG 
All PCR experiments were carried out in a Perkin-Elmer DNA thermal cycler. 
ClonePlex construction: 
The repair of fragmented insert DNA, ligation to the pLEXX-AK vector, and 
transformation into competent E. coli cells was conducted according to the protocol 
described in the ClonePlex Library Construction Kit (Lucigen). 
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